Logo

Concord Biotech Ltd. Share Price

Concord Biotech Ltd. (INR)1680.2537   (2.2%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Concord Biotech Ltd. Performance

Market performance
Open price1651.95
High1693
Volumes62058
Prev Close1680.25
Low1640.05
Closing date2025-03-21
Historical performance
1 Year High2664.00
3 Year High2664.00
5 Year High2664.00
1 Year Low1327.05
3 Year Low900.05
5 Year Low900.05

Concord Biotech Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
17576
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
57.05
Dividend Yield
Dividend Yield
0.52 %

Concord Biotech Ltd. Investment Returns

1 Year
14.6%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Concord Biotech Ltd. Technicals

IndicatorsValueSignal
5-DMA1644.1Bullish
10-DMA1653.82Bullish
20-DMA1651.4Bullish
50-DMA1927.3Bearish
100-DMA1989.89Bearish
200-DMA1871.56Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors8199884292807318329087480
Government---------------

Concord Biotech Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income338353234138
Operating Profit4660383929733417
Interest32986110
Depreciation536540500275
Profit Before Tax4126322023753127
Consolidated Net Profit3081240117492348
Adjusted EPS29231722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1051059595
Total Reserves1516212795109379899
Minority Interest------------
Total Non-Current Liabilities319321544774
Total Liabilities17007151401501913127
Capital Work in Progress21151727742179
Total Assets17007151401501913127

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities2655246020751668
Cash Flow from Investing Activities-1546-1580-1118-1952
Cash Flow from Financing Activitie-992-852-1002311
Net Cash Inflow / Outflow11628-4527
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 57.05.
  • 3Y Stock Price CAGR of the stock is 78.2.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹4660 Million.
  • The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech Ltd.

1680.2537   (2.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1122186.6
No. of Shares: 667.9
Performance:12.2%
P/L: ₹122186.6
Top Gainers
SymbolChange%
GOLDTECH57.57(20%)
BALUFORGE601.75(20%)
DBREALTY151.61(19%)
SMLISUZU1651.9(15%)
MRPL135.53(15%)
Top Losers
SymbolChange%
SALONA240.69(-7%)
AURIONPRO1417.2(-7%)
GREENLAM274.35(-6%)
BALAJEE50.94(-6%)
PGIL1287.5(-5%)
RAYMONDLSL1082.8(-5%)
AGSTRA10.7(-5%)
KESORAMIND6.41(-5%)
Similar stocks

Panacea Biotec Ltd.

38.2

447.75

February 22 - March 22

Onesource Specialty Pharma Ltd.

29.4

1648.45

February 22 - March 22

Astrazeneca Pharma India Ltd.

23.9

8510.8

February 22 - March 22

Vimta Labs Ltd.

22

1155

February 22 - March 22

Blue Jet Healthcare Ltd.

21

906.95

February 22 - March 22

Wanbury Ltd.

18.6

240.92

February 22 - March 22

Alembic Pharmaceuticals Ltd.

18.6

952.6

February 22 - March 22

Laurus Labs Ltd.

17.2

611.2

February 22 - March 22

Announcing Stock of the Month!

Stock of the Month
Stock of the Month